Further evidence of the involvement of alpha-2A-adrenergic receptor gene (ADRA2A) in inattentive dimensional scores of attention-deficit/hyperactivity disorder [4]

Molecular Psychiatry

Volumn 11, Issue 1, 2006, Pages 8-10

  Roman, T ^a   Polanczyk, G V ^b   Zeni, C ^b   Genro, J P ^b   Rohde, L A ^b   Hutz, M H ^b  

^a Federal School of Medical Sciences of Porto Alegre   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; DNA;

ALLELE; ANALYSIS OF VARIANCE; ATTENTION DEFICIT DISORDER; COMORBIDITY; DEMOGRAPHY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ELECTROPHORESIS; GENE AMPLIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; IMPULSIVENESS; INTELLIGENCE QUOTIENT; LETTER; NUCLEAR FAMILY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; HUMANS; RECEPTORS, ADRENERGIC, ALPHA-2;

EID: 32844466056     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/sj.mp.4001743     Document Type: Letter

References (10)

1. Arnsten AF, Steere JC, Hunt RD. The contribution of alpha-2-noradrenergic mechanisms to prefrontal cortical cognitive function: potential significance for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1996; 53: 448-455.
2. Biederman J, Spencer T. Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiatry 1999; 46: 1234-1242.
3. Comings DE, Gade-Andavolu R, Gonzalez N, Blake H, Wu S, MacMurray JP. Additive effect of three noradrenergic genes (ADRA2A, ADRA2C, DBH) on attention-deficit/hyperactivity disorder and learning disabilities in Tourette syndrome subjects. Clin Genet 1999; 55: 160-172.
4. Xu C, Schachar R, Tannock R, Roberts W, Malone M, Kennedy JL et al. Linkage study of the α2A-adrenergic receptor in attention-deficit/ hyperactivity disorder. Am J Med Genet (Neuropsychiatr Genet) 2001; 105: 159-162.
5. Roman T, Schmitz M, Polanczyk G, Eizirik M, Rohde LA, Hutz M. Is the α-2a adrenergic receptor gene (ADRA2A) associated with attention-deficit/hyperactivity disorder? Am J Med Genet (Neuropsychiatr Genet) 2003; 120B: 116-120.
6. Park L, Nigg JT, Waldman ID, Mummy KA, Huang-Pollock C, Rappley M et al. Association and linkage of alpha-2A-adrenergic receptor gene polymorphisms with childhood ADHD. Mol Psychiatry 2005; 10: 572-580.
7. Polanczyk G, Zeni C, Genro JP, Roman T, Hutz MH, Rohde LA. Attention-deficit/hyperactivity disorder: advancing on pharmacogenomics. Pharmacogenomics 2005; 6: 225-234.
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. Washington, DC: American Psychiatric Association, 1994.
9. Swanson JM, Kraemer HC, Hinshaw SP, Arnold LE, Conners CK, Abikoff HB et al. Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry 2001; 40: 168-179.
10. Talmud PJ, Humphries SE. Genetic polymorphisms, lipoproteins and coronary artery disease risk. Curr Opin Lipidol 2001; 12: 405-409.